ETM
MD icon

Euclidean Technologies Management’s Pediatrix Medical MD Stock Holding History

Euclidean Technologies Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,880
Closed -$709K – 74
2020
Q4 		$709K Hold
28,880
– – 0.75% 52
2020
Q3 		$470K Hold
28,880
– – 0.59% 56
2020
Q2 		$494K Sell
28,880
-45,964
-61% -$681K 0.69% 50
2020
Q1 		$871K Buy
74,844
+5,488
+8% +$113K 1.44% 40
2019
Q4 		$1.93M Buy
+69,356
New +$1.74M 2% 18

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Euclidean Technologies Management's MD Position: Q1 2021 in Review

Euclidean Technologies Management sold out of Pediatrix Medical (MD) in Q1 2021, closing a stake of 28,880 shares — an estimated $709K sold.

Euclidean Technologies Management first reported a position in MD in Q4 2019 and held it in 5 quarters. The position peaked at $1.93M in Q4 2019. 207 funds tracked by Wall St. Rank hold MD as of Q1 2021.

  • Euclidean Technologies Management reported no remaining Pediatrix Medical position as of Q1 2021 after selling out during the quarter.
  • Euclidean Technologies Management sold 28,880 Pediatrix Medical shares in Q1 2021, an estimated $709K.
  • Euclidean Technologies Management first reported a position in Pediatrix Medical in Q4 2019 and held it in 5 quarters.
  • Euclidean Technologies Management's Pediatrix Medical position peaked at $1.93M in Q4 2019.
  • 207 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2021.

Based on Euclidean Technologies Management's 13F filing for Q1 2021, filed 12 May 2021.